Anti-angiogenic agent-associated adrenal insufficiency in immune checkpoint inhibitors-treated patients

被引：3
|
作者：
Guo, Qixiang [1 ]
Lu, Wenchao [1 ]
Sun, Ximu [2 ]
Zhao, Zhixia [1 ]
Liu, Lihong [3 ]
机构：
[1] Capital Med Univ, Beijing Chaoyang Hosp, Dept Pharm, Beijing, Peoples R China
[2] Capital Med Univ, Beijing Obstet & Gynecol Hosp, Dept Pharm, Beijing, Peoples R China
[3] China Japan Friendship Hosp, Dept Pharm, Beijing, Peoples R China
来源：
EUROPEAN JOURNAL OF CANCER | 2021年 / 157卷
关键词：
D O I：
10.1016/j.ejca.2021.08.038
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：358 / 360
页数：3
相关论文
共 50 条
  • [31] Factors associated with myocarditis in patients with cancer treated with immune checkpoint inhibitors
    Izadi, Zara
    Zhang, Yan
    Lou, Youbei
    Dreyfus, Brian
    Plautz, Greg
    Wolf, Robert
    Cooper, Leslie
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [32] Treatment with the novel anti-angiogenic agent PI-88 is associated with immune-mediated thrombocytopenia
    Rosenthal, MA
    Rischin, D
    McArthur, G
    Ribbons, K
    Chong, B
    Fareed, J
    Toner, G
    Green, MD
    Basser, RL
    ANNALS OF ONCOLOGY, 2002, 13 (05) : 770 - 776
  • [33] Cediranib: profile of a novel anti-angiogenic agent in patients with glioblastoma
    Dietrich, Joerg
    Wang, Daphne
    Batchelor, Tracy T.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (10) : 1549 - 1557
  • [34] Placental lesions of vascular insufficiency are associated with anti-angiogenic state in women with preeclampsia
    Baltajian, Kedak
    Hecht, Jonathan L.
    Wenger, Julia B.
    Salahuddin, Saira
    Verlohren, Stefan
    Perschel, Frank H.
    Zsengeller, Zsuzsanna K.
    Thadhani, Ravi
    Karumanchi, S. Ananth
    Rana, Sarosh
    HYPERTENSION IN PREGNANCY, 2014, 33 (04) : 427 - 439
  • [35] Hyponatremia as a presenting symptom of secondary adrenal insufficiency induced by immune checkpoint inhibitors
    Glezerman, Ilya
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [36] Adrenal insufficiency induced by immune checkpoint inhibitors: Clinical characteristics of 145 cases
    Koshiba, K.
    ANNALS OF ONCOLOGY, 2022, 33 : S1601 - S1601
  • [37] Hyponatremia as a presenting symptom of secondary adrenal insufficiency induced by immune checkpoint inhibitors
    Glezerman, Ilya
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I1918 - I1918
  • [38] Preclinical Investigation of Immune Checkpoint Blockade and Anti-Angiogenic Therapy in Malignant Pleural Mesothelioma
    Rovers, S.
    Merlin, C.
    Fisher, S.
    Nowak, A.
    Pauwels, P.
    Lardon, F.
    Van Meerbeeck, J.
    Smits, E.
    Marcq, E.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S325 - S325
  • [39] AKI in Patients Treated with Immune Checkpoint Inhibitors
    Gupta, Shruti
    Leaf, David E.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 1 - 1
  • [40] MYOCARDITIS IN PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS
    Mahmood, Syed
    Fradley, Michael G.
    Cohen, Justine V.
    Nohria, Anju
    Reynolds, Kerry L.
    Heinzerling, Lucie M.
    Sullivan, Ryan J.
    Damrongwatanasuk, Rongras
    Chen, Carol
    Gupta, Dipti
    Kirchberger, Michael C.
    Moslehi, Javid
    Shah, Sachin
    Ganatra, Sarju
    Thavendiranathan, Paaladinesh
    Lawrence, Donald P.
    Groarke, John D.
    Neilan, Tomas G.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 699 - 699
12345